GeneDx Holdings Corp. Stock 12‑Month Price Target Raised to $85.89, Implies 27% Upside

• According to estimates from 9 analysts, GeneDx Holdings Corp. stock's average price target has risen from $82.22 to $85.89, with forecasts ranging from $63 to $103 per share
• Based on the Aug. 3 closing price, the updated target implies approximately 27% potential upside
• Consensus rating remains at “Buy” across 9 covering analysts, with 9 Buys, 0 Holds and 0 Sells

Explore more price target data and ratings for GeneDx Holdings Corp. on the , and track all previous and future analyst recommendations for GeneDx Holdings Corp. in the dedicated .

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.